Nalaganje...

A Tool to Utilize Adverse Effect Profiles to Identify Brain-Active Medications for Repurposing

BACKGROUND: To shorten the time required to bring new treatments to clinics, recent efforts have focused on repurposing existing Food and Drug Administration (FDA)-approved drugs with established safety data for new indications. We hypothesized that adverse effect profiles might aid in prioritizing...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Neuropsychopharmacol
Main Authors: McCoy, Thomas H., Perlis, Roy H.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4360243/
https://ncbi.nlm.nih.gov/pubmed/25673184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyu078
Oznake: Označite
Brez oznak, prvi označite!